References
- Shupak A, Gordon CR. Motion sickness: advances in pathogenesis, prediction, prevention, and treatment. Aviat Space Environ Med. 2006;77(12):1213-23.
- Koch A, Cascorbi I, Westhofen M, Dafotakis M, Klapa S, Kuhtz-Buschbeck JP. The Neurophysiology and Treatment of Motion Sickness. Dtsch Arztebl Int. 2018;115(41):687-96. 10.3238/arztebl.2018.0687.
- Alharbi AA, Johnson EG, Albalwi AA, Ambode OI, Cordett TK, Alshehri FH, et al. Correlation between anxiety and chronic motion sensitivity. J Vestib Res. 2022;32(2):163-70. 10.3233/ves-201625.
- Stelling D, Hermes M, Huelmann G, Mittelstädt J, Niedermeier D, Schudlik K, et al. Individual differences in the temporal progression of motion sickness and anxiety: the role of passengers’ trait anxiety and motion sickness history. Ergonomics. 2021;64(8):1062-71. 10.1080/00140139.2021.1886334.
- Takeda N, Morita M, Hasegawa S, Horii A, Kubo T, Matsunaga T. Neuropharmacology of motion sickness and emesis. A review. Acta Otolaryngol Suppl. 1993;501:10-5. 10.3109/00016489309126205.
- Lackner JR. Motion sickness: more than nausea and vomiting. Exp Brain Res. 2014;232(8):2493-510. 10.1007/s00221-014-4008-8.
- Rine RM, Schubert MC, Balkany TJ. Visual-Vestibular Habituation and Balance Training for Motion Sickness. Phys Ther. 1999;79(10):949-57. 10.1093/ptj/79.10.949.
- Wood CD, Graybiel A. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. Aerosp Med. 1968;39(12):1341-4.
- Doron O, Samuel O, Karfunkel-Doron D, Tal D. Scopolamine Treatment and Adaptation to Airsickness. Aerosp Med Hum Perform. 2020;91(4):313-7. 10.3357/amhp.5499.2020.
- Cheung B, Hofer K. Desensitization to strong vestibular stimuli improves tolerance to simulated aircraft motion. Aviat Space Environ Med. 2005;76(12):1099-104.
- Puma SC, Puma SW, inventors. Method for conditioning to prevent motion sickness. United States patent 7288057. 2007.
- Rastogi P, Khatua S. Motion Sickness Desensitisation Therapy: An Indian Experience. Indian J Aerosp Med. 2014;58(2):8-11.